Iovance Biotherapeutics, Inc. IOVA Intangibles (Net)
Intangibles (Net) at other companies
Other financials
Where this comes from
Reported directly by Iovance Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsNet.
The official record: Iovance Biotherapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Iovance Biotherapeutics, Inc.'s intangibles (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Iovance Biotherapeutics, Inc.'s intangibles (net)?
- Iovance Biotherapeutics, Inc. (IOVA) reported intangibles (net) of $269.1M in Q1 2026.
- How has Iovance Biotherapeutics, Inc.'s intangibles (net) changed year-over-year?
- Iovance Biotherapeutics, Inc.'s intangibles (net) decreased by 5.7% year-over-year, from $285.36M to $269.1M.
- What is the long-term trend for Iovance Biotherapeutics, Inc.'s intangibles (net)?
- Over 2 years (2023 to 2025), Iovance Biotherapeutics, Inc.'s intangibles (net) has grown at a 10.4% compound annual growth rate (CAGR), from $229.26M to $279.32M.
- What does intangibles (net) mean?
- Identifiable intangible assets (patents, trademarks, customer relationships, technology) net of accumulated amortization — excluding goodwill.